Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: J Am Coll Cardiol. 2019 Aug 6;74(5):617–627. doi: 10.1016/j.jacc.2019.05.064

Figure2: Forest Plots for Subgroup Analyses of Combined Outcome by Digoxin Discontinuation.

Figure2:

In all variables analyzed, patients in the digoxin discontinuation group had a lower risk of the combined endpoint of heart failure readmission or all-cause mortality compared to patients whose chronic digoxin therapy was continued. ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CI = confidence interval, SBP = systolic blood pressure. Note: Results of subgroup analyses need to be interpreted with caution as they may be false positive due to multiple comparisons and false negative due to inadequate power.